Abiraterone Acetate (II)

abiraterone acetate · Janssen Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Abiraterone Acetate (II), covering 2025-01-10 to 2025-01-10. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Study of Abiraterone Acetate (II) Versus Abiraterone Acetate in Patients with MCRPC [Phase 3]